Global Ophthalmology Therapeutics Industry Size - USD 31.87 billion by 2021Posted by rohan on October 11th, 2017 According to the report Global Ophthalmology Therapeutics Industry, published by Market Data Forecast, The Industry was worth .3 billion in 2016 and estimated to be growing at a CAGR of 7.4%, to reach .87 billion by 2021. The Industry is showcasing evident potential in the mentioned forecasting period. Ophthalmology is the branch of medicine associated with the treatment of eye defects and diseases. With the recent advancements in genetics and stem cell biology, the mechanisms of many ophthalmic diseases are being revealed progressively. Browse Industry data tables and in-depth TOC of the Global Ophthalmology Therapeutics Industry to 2021 @ http://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/ Global Industry for Ophthalmology Therapeutics is driven by the growing prevalence for vision impairment, which was estimated to be 147 million in 2010, and is estimated to reach 191 million in the world in 2020. Technological advancement in the field of medicine are also playing a major role in the growth of the Industry. Increasing geriatric population around the globe along with rise in disposable income are some of the other factors driving the Industry for Ophthalmology Therapeutics Industry. However, lack of awareness about the various diseases associated with ophthalmology is a major factor restraining the growth of the Industry. Stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for Industry growth. The Global Industry for Ophthalmology Therapeutics is broadly categorized into Indication and End User. On the basis of indication global Ophthalmology Therapeutics Industry is segmented into Glaucoma, Dry Eye Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest indication segment accounting for a share of approximately 31% followed by AMD with a share of 27%. Based on end User the Industry is segmented into Hospitals, Eye Clinics, Diagnostic Centres and Patients. Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/global-ophthalmology-therapeutics-market-1106/request-sample On the basis of geography, the global Industry is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East. North America is the dominating Industry for Ophthalmology Therapeutics accounting for a share of approximately xx% followed by Europe. Asia-Pacific is estimated to be the fastest growing region with a CAGR of xx% during the forecast period of 2016-2021. Pfizer Inc., Allergan Inc., Alcon Inc., Merck & co. Inc. and Roche are the major companies in the Industry accounting for a share of approximately 70%. Other major companies covered in the report are Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye Gate Pharmaceuticals Key Points from Table of Contents Overview
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) Industry: Segmentation
Geographical Analysis
Strategic Analysis
Industry Leaders' Analysis Competitive Landscape About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
Like it? Share it! More by this author |